the National Colorectal Cancer Cohort (NCRCC) Study: National Colorectal Cancer Research Consortium
NCT ID: NCT04074538
Last Updated: 2019-08-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
55000 participants
OBSERVATIONAL
2013-01-01
2035-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. To assess risk factors for colorectal cancer and evaluate risk prediction model of colorectal cancer to identify the high-risk population.
2. To discover, test and validate new biological markers (e.g. genetic, epigenetic, transcriptomic, metabolomics, proteomic and metagenomics biomarkers) for early diagnosis, prediction of clinical outcomes (e.g. therapeutic response, toxicity, surgical complications) and survivorship endpoints (e.g. recurrence, survival, quality of life, second primary cancer).
3. To estimate associations of epidemiological determinants (e.g. medication and supplement use, diet, lifestyle pattern) with clinical outcomes and survivorship endpoints among CRC patients.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Mentally/physically able to consent and participate
* Subjects aged ≥18 years old (Colorectal Cancer Patient Cohort, CRCPC), age 40-74 years (CRC Screening Cohort, CRCSC)
* Newly-diagnosed colon and rectal cancer for stages Ⅰ-Ⅳ (CRCPC)
Exclusion Criteria
* Non-Chinese speaking
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
OTHER
West China Hospital
OTHER
Sun Yat-sen University
OTHER
Shanghai Zhongshan Hospital
OTHER
Peking University People's Hospital
OTHER
Peking University Cancer Hospital & Institute
OTHER
Fujian Cancer Hospital
OTHER_GOV
Hubei Cancer Hospital
OTHER
The First Affiliated Hospital with Nanjing Medical University
OTHER
Shanxi Province Cancer Hospital
OTHER
Changhai Hospital
OTHER
Zhejiang Cancer Hospital
OTHER
Third Affiliated Hospital of Third Military Medical University
OTHER
Air Force Military Medical University, China
OTHER
Sixth Affiliated Hospital, Sun Yat-sen University
OTHER
Ding Ke-Feng
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ding Ke-Feng
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Second Affiliated Hospital Zhejiang University College of Medicine
Hangzhou, Zhejiang, China
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Beijing, , China
West China Hospital
Chengdu, , China
Sun Yat-sen University
Guangzhou, , China
Shanghai Zhongshan Hospital
Shanghai, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ke-Feng Ding, PhD/MD
Role: primary
Zheng Zhaoxu
Role: primary
Wang Ziqiang
Role: primary
Pan Zhizhong
Role: primary
Wei Ye
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Huang F, Jiang S, Wei R, Xiao T, Wei F, Zheng Z, Liu Q. Association of resection margin distance with anastomotic recurrence in stage I-III colon cancer: data from the National Colorectal Cancer Cohort (NCRCC) study in China. Int J Colorectal Dis. 2024 Jul 12;39(1):105. doi: 10.1007/s00384-024-04684-x.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRCCZ-ncrcc
Identifier Type: -
Identifier Source: org_study_id